awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38497691-3E80755C-78B2-4EB9-ADFA-A50B06E2C985
Q38497691-3E80755C-78B2-4EB9-ADFA-A50B06E2C985
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38497691-3E80755C-78B2-4EB9-ADFA-A50B06E2C985
Once-weekly exenatide as a treatment for Type 2 diabetes.
P2860
Q38497691-3E80755C-78B2-4EB9-ADFA-A50B06E2C985
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38497691-3E80755C-78B2-4EB9-ADFA-A50B06E2C985
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
adf61c6da6479188aa940357dffa255477bd96a9
P2860
Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study.